Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -152,188 | -78,685 | -258,757 | -177,440 | -110,396 |
| Depreciation Amortization | -572 | 224 | -2,475 | -2,409 | -2,215 |
| Accounts receivable | 1,785 | 1,785 | -1,315 | 610 | 610 |
| Other Working Capital | 12,827 | 4,347 | 14,058 | 5,524 | -4,279 |
| Other Operating Activity | 15,150 | 6,741 | 37,544 | 26,710 | 17,903 |
| Operating Cash Flow | $-122,998 | $-65,588 | $-210,945 | $-147,005 | $-98,377 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -178,585 | 73,758 | 211,786 | 155,080 | 93,793 |
| PPE Investments | -4,818 | -1,639 | -2,714 | -1,433 | -993 |
| Investing Cash Flow | $-183,403 | $72,119 | $209,072 | $153,647 | $92,800 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 324,984 | 327 | 2,388 | 1,039 | 265 |
| Financing Cash Flow | $324,984 | $327 | $2,388 | $1,039 | $265 |
| Beginning Cash Position | 28,871 | 28,871 | 28,356 | 28,356 | 28,356 |
| End Cash Position | 47,454 | 35,729 | 28,871 | 36,037 | 23,044 |
| Net Cash Flow | $18,583 | $6,858 | $515 | $7,681 | $-5,312 |
| Free Cash Flow | |||||
| Operating Cash Flow | -122,998 | -65,588 | -210,945 | -147,005 | -98,377 |
| Capital Expenditure | -4,818 | -1,639 | -2,714 | -1,433 | -993 |
| Free Cash Flow | -127,816 | -67,227 | -213,659 | -148,438 | -99,370 |